Abbott Laboratories Share Price Börse Stuttgart
Stocks
ABL
US0028241000
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Tradegate
12:07:51 05/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 87.03 EUR | +0.66% |
|
-2.68% | -18.02% |
| 02/10 | Weak Jobs Lead to Stronger Stocks |  |
| 02/10 | Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms | RE |
| Market Cap | 17TCr 15TCr 14TCr 13TCr 24TCr 16,21900Cr 24TCr 1,69300Cr 66TCr 8,29100Cr 63TCr 62TCr 26,61000Cr | P/E 2026 * |
27.6x | P/E 2027 * | 21.4x |
|---|---|---|---|---|---|
| Enterprise Value | 19TCr 17TCr 16TCr 15TCr 27TCr 18,52000Cr 28TCr 1,93300Cr 75TCr 9,46800Cr 72TCr 71TCr 30,38500Cr | EV / Sales 2026 * |
3.84x | EV / Sales 2027 * | 3.48x |
| Free-Float |
86.16% | Yield 2026 * |
2.64% | Yield 2027 * | 2.81% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABT | Delayed | |
CBOE
| ABT | Real-time | |
|
Xetra
| ABL | Delayed | |
|
CBOE
| ABT | Real-time | |
|
CBOE
| Real-time | ||
|
London S.E.
| ABT | Delayed | |
|
Tradegate
| ABL | Real-time | |
|
Deutsche Boerse AG
| ABL | Delayed | |
|
Borsa Italiana
| 1ABT | End-of-day quote | |
|
Boerse Muenchen
| ABL | Real-time | |
|
Mexican S.E.
| ABT * | End-of-day quote | |
|
Kazakhstan S.E.
| ABT_KZ | End-of-day quote | |
|
Lima
| ABTUS | End-of-day quote | |
|
Wiener Boerse
| ABT | End-of-day quote | |
|
Swiss Exchange
| ABT | Delayed | |
|
Santiago S.E.
| ABTCL | End-of-day quote | |
|
Börse Stuttgart
| ABL | Delayed | |
|
Santiago S.E.
| ABT | End-of-day quote |
Last Transcript: Abbott Laboratories
| 1 week | -2.68% | ||
| Current month | -0.98% | ||
| 1 month | -9.35% | ||
| 3 months | +3.89% | ||
| 6 months | -2.98% | ||
| Current year | -18.02% |
| 1 week | 85.02 |  | 89.44 |
| 1 month | 85.02 | | 95.72 |
| 3 years | 69.64 | | 134.1 |
| 5 years | 69.64 | | 134.1 |
| 10 years | 34 | | 134.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 16/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.66% | -2.68% | -23.64% | -4.55% | 17TCr | |
| +0.84% | -3.74% | -27.56% | +1.93% | 17TCr | |
| -0.07% | -2.55% | -11.59% | +13.26% | 11TCr | |
| +0.90% | +1.13% | -25.66% | +3.47% | 11TCr | |
| -1.24% | -0.76% | -49.50% | -12.46% | 7.39TCr | |
| -0.24% | +0.69% | +2.08% | +69.19% | 5.9TCr | |
| +1.59% | +4.18% | +8.91% | +62.37% | 5.13TCr | |
| -0.71% | -3.82% | -8.68% | -31.93% | 4.82TCr | |
| +0.12% | -0.17% | -17.87% | +19.66% | 4.08TCr | |
| -1.01% | -1.45% | +27.31% | -2.67% | 3.22TCr | |
| Average | +0.02% | -0.86% | -12.62% | +11.83% | 7.67TCr | |
| Weighted average by Cap. | +0.21% | -1.30% | -18.60% | +8.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.02TCr 4.46TCr 4.16TCr 3.79TCr 7.16TCr 4,82600Cr 7.22TCr 50TCr 20TCr 2,46700Cr 19TCr 18TCr 7,91800Cr | 5.45TCr 4.85TCr 4.52TCr 4.12TCr 7.77TCr 5,24200Cr 7.85TCr 55TCr 21TCr 2,68000Cr 20TCr 20TCr 8,60100Cr |
| Net income | 630.23Cr 559.96Cr 522.63Cr 476.36Cr 898.41Cr 61TCr 906.78Cr 6.32TCr 2.45TCr 31TCr 2.37TCr 2.31TCr 99TCr | 797.8Cr 708.85Cr 661.59Cr 603.02Cr 1.14TCr 77TCr 1.15TCr 8.01TCr 3.1TCr 39TCr 3TCr 2.93TCr 1,25800Cr |
| Net Debt | 2.39TCr 2.13TCr 1.99TCr 1.81TCr 3.41TCr 2,30100Cr 3.44TCr 24TCr 9.31TCr 1,17600Cr 8.99TCr 8.79TCr 3,77600Cr | 2.1TCr 1.86TCr 1.74TCr 1.58TCr 2.99TCr 2,01500Cr 3.02TCr 21TCr 8.15TCr 1,03000Cr 7.87TCr 7.7TCr 3,30500Cr |
| Date | Price | Change |
|---|---|---|
| 05/26/05 | €86.68 | +0.25% |
| 02/26/02 | €86.46 | +0.61% |
| 01/26/01 | €85.94 | -1.58% |
| 30/26/30 | €87.32 | -1.78% |
| 29/26/29 | €88.90 | +0.16% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABL Stock
Select your edition
All financial news and data tailored to specific country editions
